Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization

Some studies have shown that sorafenib could significantly prolong the overall survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization (TACE). However, other studies revealed that patients had no access to sorafenib-related survival benef...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Kun He, Zelong Yang, Xinyu Liu, Yanling Yang, Wenjie Song, Shangyu Wang, Yong Chen
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2022-12-01
Цуврал:	Current Oncology
Нөхцлүүд:	predictors hepatocellular carcinoma vascular endothelial growth factor transcatheter arterial chemoembolization sorafenib
Онлайн хандалт:	https://www.mdpi.com/1718-7729/30/1/38
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!